CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (BMY) (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis ® (apixaban), an oral anticoagulant relied ...
Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback